Aptus Pharma share price
You have to be logged in to add this to Watchlist.- ₹216.10(-2.00%)June 12, 2026 15:15:00 PM IST
- NSE
- BSE
- Vol : 20.80 K (NSE + BSE)Last 20 day avg : 19.62 K
Aptus Pharma is trading -2.00% lower at Rs 216.10 as compared to its last closing price. Aptus Pharma has been trading in the price range of 216.10 & 216.10. Aptus Pharma has given 218.73% in this year & -5.90% in the last 5 days. Aptus Pharma has TTM P/E ratio 51.83 as compared to the sector P/E of 27.46.The company posted a net profit of 2.87 Crores in its last quarter.Listed peers of Aptus Pharma include Sun Pharmaceutical Industries (0.72%), Torrent Pharmaceuticals (0.15%), Divi's Laboratories (-0.34%).The Mutual Fund holding in Aptus Pharma was at -% in . The MF holding has - from the last quarter. The FII holding in Aptus Pharma was at 10.03% in 30 Sep 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jun 15, 2026, 02:50 AM UTC
- Debt To EquityIn line with industry0.31The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.41The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bullish | 1,807.25 | 0.72 | 4,32,524.85 | 37.11 | 5.91 | 0.93 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 4,577.00 | 0.15 | 1,54,232.03 | 74.30 | 18.87 | 0.83 | 17.62 |
| Divi's Laboratories | Bullish | 6,628.80 | -0.34 | 1,75,426.53 | 79.06 | 11.59 | 0.46 | 0.01 |
| Dr Reddy's Laboratories | Bullish | 1,273.80 | -0.10 | 1,06,313.63 | 19.57 | 3.3 | 0.60 | 2.34 |
| Cipla | Moderately Bullish | 1,388.80 | 0.42 | 1,12,187.34 | 20.21 | 3.41 | 0.99 | 0.81 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-06-12 | Preferential Issue of shares & Others |
| 2026-04-27 | Audited Results |
| 2026-03-24 | Bonus issue & Others |
| 2025-11-10 | Half Yearly Results |
- IndustryBiotechnology & Drugs
- ISININE15XJ01010
- BSE Code544529
- NSE Code
Aptus Pharma is trading at 216.10 as on Fri Jun 12 2026 09:45:00. This is -2.00% lower as compared to its previous closing price of 220.50.
The market capitalization of Aptus Pharma is 370.61 Cr as on Fri Jun 12 2026 09:45:00.
The 52 wk high for Aptus Pharma is 238.80 whereas the 52 wk low is 32.32
Aptus Pharma can be analyzed on the following key metrics -
- TTM P/E: 51.83
- Sector P/E: 27.46
- Dividend Yield: 0.00%
- D/E ratio: 0.31
Aptus Pharma reported a net profit of 4.62 Cr in 2026.
EQUITY QUICK LINKS
Aptus Pharma QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.